Document:

Exhibit
10.2

 

THIS
NOTE AND THE SECURITIES ISSUABLE UPON THE CONVERSION HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED.
THEY MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT AS TO THE
SECURITIES UNDER SAID ACT OR AN OPINION OF COUNSEL SATISFACTORY TO THE CORPORATION THAT SUCH REGISTRATION IS NOT REQUIRED.

 

H-CYTE,
INC.

 

SECURED
CONVERTIBLE PROMISSORY NOTE

 

	$[________________]	[_________________, 2020]

 

FOR
VALUE RECEIVED, H-Cyte, Inc., a Nevada corporation (“Maker”), promises to pay to [PURCHASER] (“Holder”),
the sum of [_____________] ($___________) (the “Principal Balance”), together with simple interest from the
date of this Secured Convertible Promissory Note (this “Note”) on the unpaid Principal Balance at a rate equal
to 12% per annum (subject to Section 16 below), computed on the basis of the actual number of days elapsed and a year of
365 or 366 days, as the case may be. This Note is one of the “Notes” issued pursuant to the Secured Convertible Note
and Warrant Purchase Agreement, dated as of April [__], 2020 (as amended or supplemented, the “Purchase Agreement”)
between Maker, Holder and the other purchasers thereunder and the holders of other Notes are sometimes referred to herein as “Holders”.

 

The
following is a statement of the rights of Holder and the conditions to which this Note is subject, and to which Holder, by the
acceptance of this Note, agrees:

 

1.
Definitions. All capitalized terms used but not defined in this Note have the meanings given to them in the Purchase
Agreement.

 

2.
Maturity Date. Unless this Note is converted under Section 8 or prepaid in full pursuant to Section 4,
the unpaid Principal Balance, together with any accrued but unpaid interest under this Note, shall be due and payable by Maker
on October 31, 2020 (the “Maturity Date”).

 

3.
Security. This Note is secured by the collateral of the Company pledged by the Company to the Holders pursuant to
that certain Security Agreement (as it may be amended, the “Security Agreement”) dated as of the date hereof,
among the Company, the existing subsidiaries of the Company and the Lead Purchaser (as agent for the Holders).

 

4.
Prepayment. Except as provided in Section 8(b) with respect to a Sale of the Company, this Note and all or
any Principal Balance or interest hereunder may not be prepaid by Maker without the prior written consent of the Lead Purchaser.

 

5.
Notice of Sale of the Company. In the event that Maker takes any action to approve or enter into any transaction
constituting a Sale of the Company, Maker shall provide Holder with at least ten (10) days’ prior written notice of the
anticipated closing date of such transaction. A “Sale of the Company” means (a) the closing of the sale, transfer
or other disposition, in a single transaction or series of related transactions, or all or substantially all of the Maker’s
assets, (b) a transaction or series of related transactions in which a Person, or a group of related Persons, acquires from stockholders
of the Maker shares representing more than fifty percent (50%) of the outstanding voting power of the Maker; or (c) a transaction
that qualifies as a “Deemed Liquidation Event” as defined in the Certificate. For the avoidance of doubt, a transaction
will not constitute a “Sale of the Company” if its sole purpose is to change the state of Maker’s incorporation
or to create a holding company that will be owned in substantially the same proportions by the persons who held Maker’s
securities immediately prior to such transaction.

 

    	 	 	 

     

    

 

6.
Events of Default. The occurrence of any of the following shall constitute an “Event of Default”
under this Note:

 

(a)
Failure to Pay. Maker fails to make any payment of principal or interest when due under the terms of this Note; provided
that a failure to pay the Principal Balance and all accrued but unpaid interest at the Maturity Date shall only constitute
an Event of Default if such failure continues unremedied for a period of ten (10) days following the Maturity Date after written
notice from the Lead Purchaser;

 

(b)
Involuntary Bankruptcy or Insolvency Proceedings. Proceedings for the appointment of a receiver, trustee, liquidator
or custodian of Maker or of all or a substantial part of the property of Maker, or an involuntary case or other proceedings seeking
liquidation, reorganization or other relief with respect to Maker or the debts of Maker under any bankruptcy, insolvency or other
similar law now or hereafter in effect are commenced and an order for relief entered or such proceeding is not dismissed or discharged
within ninety (90) days of such commencement; or

 

(c)
Voluntary Bankruptcy or Insolvency Proceedings. Maker (i) applies for or consents to the appointment of a receiver,
trustee, liquidator or custodian of itself or of all or a substantial part of its property, (ii) admits in writing to its inability
to pay its debts generally as they mature, (iii) makes a general assignment for the benefit of its or any of its creditors, (iv)
is dissolved or liquidated, (v) commences a voluntary case or other proceeding seeking liquidation, reorganization or other relief
with respect to itself or its debts under any bankruptcy, insolvency or other similar law now or hereafter in effect or consents
to any such relief or to the appointment of or taking possession of its property by any official in an involuntary case or other
proceeding commenced against it.

 

(d)
Breach of Purchase Agreement. Any breach of or default under the Purchase Agreement that remains uncured for ten (10) days
after written notice from the Lead Purchaser.

 

7.
Rights of Holder upon Default. Upon the occurrence or existence of any Event of Default (other than an Event of
Default referred to in Sections 6(b) and 6(c)) and at any time thereafter during the continuance of such Event of
Default, Holder may, by written notice to Maker and with the prior written consent of the Lead Purchaser, declare the outstanding
Principal Balance, together with accrued interest, to be immediately due and payable without presentment, demand, protest or any
other notice of any kind, all of which are hereby expressly waived. Upon the occurrence or existence of any Event of Default described
in Sections 6(b) and 6(c), immediately and without notice, the outstanding Principal Balance, together with accrued
interest, shall automatically become immediately due and payable, without presentment, demand, protest or any other notice of
any kind, all of which are hereby expressly waived. In addition to the foregoing remedies, upon the occurrence or existence of
any Event of Default and at any time thereafter during the continuance of such Event of Default, Holder may, with the prior written
consent of the Lead Purchaser, exercise any other right, power or remedy, either by suit in equity or by action at law, or both.
All of the rights, powers and remedies of Holder shall be cumulative, and may be exercised independently, concurrently or successively
in Holder’s sole discretion. No waiver by Holder of any default shall operate as a waiver of any other default or of the
same default on a future occasion. No delay or omission on the part of Holder in exercising any right or remedy shall operate
as a waiver thereof and no single or partial exercise by Holder of any right or remedy shall preclude any other or future exercise
thereof or the exercise of any other right or remedy.

 

    	 	2	 

     

    

 

8.
Conversion.

 

(a)
Mandatory Conversion Upon Qualified Financing Closing. If any and all amounts due hereunder are not paid in full on or
before the Qualified Financing Closing, concurrently with the Qualified Financing Closing and subject to the terms and conditions
set forth herein, the entire Principal Balance of this Note, together with any accrued and unpaid interest thereon, shall automatically
convert into fully paid and non-assessable shares (rounded up to the nearest whole share) of the series of preferred stock of
Maker issued pursuant to such Qualified Financing (the “New Securities”), such conversion in each case to occur
concurrently with the Qualified Financing Closing. The number of shares of New Securities to be issued to Holder upon conversion
of this Note pursuant to a Qualified Financing shall be equal to the product of (x) the Conversion Multiple and (y) the quotient
obtained by dividing the entire Principal Balance of this Note, together with any accrued and unpaid interest thereon, as of the
date of conversion, by the Conversion Price. The “Conversion Multiple” shall be equal to one (1), provided,
that upon the occurrence of a Purchaser Subscription Default with respect to the Holder, the Conversion Multiple under this Note
shall be automatically reduced to one-half (0.5) and instead of converting into the shares of New Securities in connection with
such Qualified Financing, the Note shall convert into shares of Common Stock. The “Conversion Price” shall
be equal to the lesser of (i) the price per share paid by the investors in such Qualified Financing for such New Securities (which
are purchased for cash and not through conversion of Notes) and (ii) the price per share obtained by dividing (x) $3,000,000 by
(y) the number of Fully-Diluted Shares outstanding immediately prior to the Qualified Financing Closing. “Fully-Diluted
Shares” means all outstanding shares of capital stock of the Maker, assuming (A) the conversion of all convertible preferred
stock and the conversion or exercise of warrants, options and all other securities convertible into or exercisable for shares
of capital stock in the Maker (other than the Notes) regardless of whether such convertible securities are “in the money”,
and (B) the issuance of all shares of capital stock reserved for issuance under any equity plan of the Maker, including any additional
stock reserved in connection with the Qualified Financing. The issuance of any New Securities pursuant to the conversion of the
Note in connection with the Qualified Financing shall be upon and subject to the same terms and conditions applicable to the New
Securities sold in the Qualified Financing.

 

(b)
Conversion or Repayment Upon a Sale of the Company.

 

(i)
In the event of a Sale of the Company prior to the Qualified Financing Closing or the Maturity Date, the Holder shall be entitled,
at the election of the Holder, either (A) to receive payment of the outstanding Principal Balance of, together with any accrued
and unpaid interest thereon, this Note as of the initial closing of the Sale of the Company, in such form of consideration as
is paid to the Maker’s shareholders in such Sale of the Company, or (B) to convert the outstanding Principal Balance together
with any accrued and unpaid interest thereon, immediately prior to the closing of the Sale of the Company, into the number of
shares of the Company’s Series D Preferred Stock, par value $0.001 per share (the “Series D Preferred Stock”)
as is equal to the product of (x) two (2) and (y) the quotient obtained by dividing the outstanding Principal Balance and unpaid
interest on this Note as of the date of conversion by the Sale Conversion Price. “Sale Conversion Price” means
a price per share equal to the lesser of (x) 75% of the gross per-share consideration a holder of Series D Preferred Stock (excluding
for purposes of this calculation any holders receiving shares of Series D Preferred Stock upon conversion of their Notes immediately
prior to such Sale of the Company event) receives or is deemed to have received with respect to each such share of Shares D Preferred
Stock in such Sale of the Company (assuming the Series D Preferred Stock did not convert into shares of Common Stock in connection
with such Sale of the Company) and (y) the price per share obtained by dividing (I) $3,000,000 by (II) the number of Fully-Diluted
Shares outstanding immediately prior to the closing of the Sale of the Company, such conversion in each case to occur (or be given
effect) immediately prior to the closing of such Sale of the Company.

 

    	 	3	 

     

    

 

(ii)
Maker shall give Holder written notice of any Sale of the Company at least ten (10) days prior to the anticipated closing date
thereof, and Holder shall give Maker written notice of their election in accordance with the foregoing at least five (5) days
prior to such anticipated closing date. Holder acknowledges and agrees that the conversion of the Notes in connection with a Sale
of the Company may be conditioned upon Holder’s execution of certain agreements and consents in the form agreed to by Maker
and the acquiring party in the Sale of the Company including, without limitation, representations, warranties, escrows and indemnifications,
if any, relating to the Conversion Shares issued upon conversion of the Notes.

 

(c)
Optional Conversion. If a Qualified Financing Closing does not take place on or prior to the Maturity Date, at any time
on or after the Maturity Date, at the election of the Lead Purchaser, this Note together with all other Notes shall be converted
into the number of shares of Series D Preferred Stock of the Company as is equal to the quotient obtained by dividing the outstanding
Principal Balance and unpaid interest on this Note as of the date of conversion by the product of (x) 50 and (y) the quotient
obtained by dividing (A) $3,000,000 by (B) the number of Fully-Diluted Shares outstanding immediately prior to the date of such
conversion (subject to adjustments for stock dividends, splits, combinations and similar events).

 

(d)
Conversion Procedure. Upon the conversion of this Note, the Principal Balance, together with any accrued and unpaid
interest thereon, shall be converted into Conversion Shares, shares of Common Stock or shares of Series D Preferred Stock, as
applicable, in each case held by the Holder. The Company will not be required to issue or deliver the Conversion Shares, shares
of Common Stock or shares of Series D Preferred Stock, as applicable, until the Holder has surrendered this Note to the Company
(or provided an instrument of cancellation or affidavit of lost note). Upon a conversion under Section 8(a) or 8(c),
Maker shall, within five (5) Business Days after such delivery, or such agreement and indemnification, issue and deliver certificates
representing the number of fully paid and non-assessable shares of the New Securities, shares of Common Stock or Series D Preferred
Stock, as applicable, into which the Note converts in accordance with the agreed conversion terms (bearing such legends as are
required by the Purchase Agreement). Maker shall take all action to designate and authorize a sufficient number of shares of stock
to be issued upon conversion to the New Securities, shares of Common Stock or Series D Preferred Stock, as applicable, following
a conversion pursuant to this Section 8.

 

(e)
Joinder to Investment Documents. If this Note is converted into any shares of equity securities, Maker will prepare any
joinder or amendment to any applicable Existing Investment Documents as necessary or appropriate to expressly include Holder and
its shares of equity securities received upon such conversion as an investor under such document(s) (with such adjustments and
limitations as may apply for such equity securities of that type and due to the amount of Holder’s stock ownership), and
Holder and Maker will execute same.

 

(f)
Effect of Conversion. Upon conversion of this Note in full, Maker shall be forever released from all its obligations
and liabilities under this Note and the Note shall be deemed to be cancelled as of such time and any collateral of the Company
pledged under the Security Agreement shall be released.

 

9.
Pari Passu Notes. Holder acknowledges and agrees that the payment of all or any portion of the outstanding Principal
Balance of this Note and all interest hereon shall be pari passu in right of payment and in all other respects to the other
convertible promissory note(s) issued pursuant to the Purchase Agreement or pursuant to the terms of such notes. Maker shall make
any payments under this Note and such other notes pro rata among the Holders of such notes based on the respective principal balances
(together with any accrued and unpaid interest thereon) outstanding under them at the time of payment.

 

    	 	4	 

     

    

 

10.
Successors and Assigns. Subject to the restrictions on transfer described in Sections 12 and 13 below,
the rights and obligations of Maker and Holder shall be binding upon and benefit the successors, assigns, heirs, administrators
and transferees of the parties.

 

11.
Waiver and Amendment. Any term, covenant, agreement or condition of this Note may be amended, and compliance therewith
may be waived (either generally or in a particular circumstance and either retroactively or prospectively), in the manner specified
in Section 8.12 of the Purchase Agreement. Any amendment or waiver in accordance with this Section 11 will be binding upon
each of Maker, Holder, and any subsequent holder of this Note.

 

12.
Transfer of this Note by Holder. Holder may not assign, pledge, or otherwise transfer this Note without the prior
written consent of Maker and the Lead Purchaser, except that Holder may assign this Note and its rights hereunder to any Affiliate
of Holder; provided that Maker is given written notice at the time of such assignment stating the name and address of the
assignee and such assignee agrees in writing to be bound by the terms of this Note, the Purchase Agreement and the other Transaction
Documents. Subject to the foregoing, this Note may be transferred only upon compliance with the securities law restrictions set
forth in this Note, the Purchase Agreement and the other Transaction Documents, the surrender of the original Note for registration
of transfer, duly endorsed, or accompanied by a duly executed written instrument of transfer in form satisfactory to Maker and
its counsel. Thereupon, a new note for the same Principal Balance and interest will be issued to, and registered in the name of,
the assignee. Interest and Principal Balance amounts are payable only to the registered holder of this Note.

 

13.
Assignment by Maker. Neither this Note nor any of the rights, interests or obligations hereunder may be assigned,
by operation of law or otherwise, in whole or in part, by Maker without the prior written consent of Holder.

 

14.
Notices. All notices, requests, demands, consents, instructions or other communications required or permitted hereunder
shall be made and effective as set forth in the Purchase Agreement.

 

15.
Payment. All payments of Principal Balance, interest and any other amounts (other than by conversion) shall be made
in lawful money of the United States of America and in immediately available funds at such place as Holder may from time to time
designate in writing to Maker. Payment shall be credited first to Holder expenses, second to accrued interest then due and payable,
if any, and then the remainder applied to the Principal Balance. All payments by the Maker under this Note shall be made without
set-off or counterclaim and be free and clear and without any deduction or withholding for any taxes or fees of any nature whatsoever,
unless the obligation to make such deduction or withholding is imposed by law. The Maker shall pay and save Holder harmless from
all liabilities with respect to or resulting from any delay or omission to make any such deduction or withholding required by
law.

 

16.
Usury; Default Interest. During any period in which an Event of Default has occurred and is continuing, the Maker
shall pay interest on the unpaid Principal Balance of this Note at a rate per annum equal to the rate otherwise applicable hereunder
plus 6%. In the event any interest is paid on this Note which is deemed to be in excess of the then legal maximum rate, then that
portion of the interest payment representing an amount in excess of the then legal maximum rate shall be deemed a payment of Principal
Balance and applied against the Principal Balance of this Note.

 

17.
Coordinated Action. Holder may not institute any action to collect this Note or any other action with respect to
this Note or the obligations hereunder without the prior written consent of the Lead Purchaser, as Agent for all Holders. In connection
therewith, the provisions of Section 7 of the Purchase Agreement will apply, mutatis mutandis, with respect to any action
taken by the Agent on behalf of all Holders. The Lead Purchaser, or any successor Agent, shall be an express third party beneficiary
of the provisions of this Section 17.

 

    	 	5	 

     

    

 

18.
Prevailing Party. In any action at law or in equity to enforce or construe any provisions or rights under this Note,
the non-prevailing party to such litigation, as determined by a court pursuant to a final order, judgment or decree, shall pay
to the prevailing party all costs, expenses and reasonable attorneys’ fees incurred by such prevailing party (including,
without limitation, such costs, expenses and fees on any appeal), which costs, expenses and attorneys’ fees shall be included
as part of any order, judgment or decree.

 

19.
Loss of Note. Upon receipt by Maker of evidence satisfactory to it of the loss, theft, destruction or mutilation
of this Note or any Note exchanged for it, and indemnity satisfactory to the Maker (in case of loss, theft or destruction) or
surrender and cancellation of such Note (in the case of mutilation), Maker will (at Holder’s expense) make and deliver in
lieu of such Note a new Note of like tenor.

 

20.
Saturdays, Sundays, Holidays. If any date that may at any time be specified in this Note as a date for the making
of any payment of principal or interest under this Note shall fall on Saturday, Sunday or legal holiday in the State of Florida,
then the date for the making of that payment shall be the next subsequent day which is not a Saturday, Sunday, or legal holiday.

 

21.
Governing Law; Jurisdiction and Venue. The provisions of Sections 8.4 and 8.5 of the Purchase Agreement will apply,
mutatis mutandis, with respect to any dispute arising out of this Note.

 

22.
Waiver of Jury Trial. EACH PARTY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY RIGHT IT MAY HAVE
TO A TRIAL BY JURY IN RESPECT OF ANY SUIT, ACTION OR PROCEEDING DIRECTLY OR INDIRECTLY ARISING OUT OF, UNDER OR IN CONNECTION
WITH THIS NOTE.

 

23.
No Rights as a Stockholder. Nothing contained in this Note shall be construed as conferring upon Holder, prior to
the conversion of this Note, any rights of a shareholder of Maker, including the right to vote or to receive dividends, solely
as it relates to this Note.

 

24.
Time is of the Essence. Time is of the essence with respect to the payment and performance of the obligations of
this Note.

 

25.
Acceptance of Note. By acceptance of this Note, the Holder accepts and agrees to be bound by all of the terms and
provisions set forth herein.

 

26.
Documentary Stamp Taxes. MAKER SHALL BE LIABLE FOR DOCUMENTARY STAMP TAXES AND ANY PENALTIES AND INTEREST ASSOCIATED
WITH THAT TAX PAYABLE WITH RESPECT TO THIS NOTE, AND ANY SUBSEQUENT RENEWALS, MODIFICATIONS OR AMENDMENTS OF THIS NOTE.

 

[Signature
page follows]

 

    	 	6	 

     

    

 

IN
WITNESS WHEREOF, Maker has caused this Note to be issued as of the date first written above.

 

	 	H-CYTE, INC.,

                                                                     a Nevada corporation

	 	 
	 	By:	 
	 	Name:	William
    E. Horne
	 	Title:	Chief
    Executive Officer

 

Form
of Secured Convertible Promissory Note Payable to [PURCHASER]Exhibit
10.3

 

THIS
SECURITY HAS NOT BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE
UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY,
MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE
EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH
APPLICABLE STATE SECURITIES LAWS. THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT WITH A REGISTERED
BROKER-DEALER OR OTHER LOAN WITH A FINANCIAL INSTITUTION THAT IS AN “ACCREDITED INVESTOR” AS DEFINED IN RULE 501(a)
UNDER THE SECURITIES ACT OR OTHER LOAN SECURED BY SUCH SECURITIES.

 

THE
SECURITIES REPRESENTED BY THIS INSTRUMENT ARE SUBJECT TO THAT CERTAIN VOTING AGREEMENT, INVESTORS’ RIGHTS AGREEMENT AND
RIGHT OF FIRST REFUSAL AGREEMENT, EACH DATED NOVEMBER 15, 2019, BY AND AMONG THE COMPANY AND CERTAIN OF ITS STOCKHOLDERS.

 

THE
TRANSFER OF THIS WARRANT IS RESTRICTED AS DESCRIBED HEREIN.

 

H-CYTE,
INC.

 

Warrant
for the Purchase of Shares of Common Stock, par value $0.001 per share

 

Original
Issue Date: ___________, 2020

 

THIS
CERTIFIES that, for value received, [Name of Holder], whose address is [______] (the “Holder”), is entitled
to subscribe for and purchase from H-Cyte, Inc., a Nevada corporation f/k/a Medovex Corp. (the “Company”),
upon the terms and conditions set forth herein, up to the number of Warrant Shares at a purchase price per share equal to the
Exercise Price, subject to the provisions and upon the terms and conditions set forth herein. This Warrant was issued to the Holder
in connection with the transactions contemplated by that certain Secured Convertible Note and Warrant Purchase Agreement (the
“Purchase Agreement”), dated April __, 2020, among the Company and the Purchasers signatory thereto.

 

The
number of shares of Common Stock issuable upon exercise of this Warrant (the “Warrant Shares”) and the Exercise
Price may be adjusted from time to time as hereinafter set forth.

 

1.
Definitions. Capitalized terms used in this Warrant but not defined herein shall have the meanings ascribed to such terms
in the Purchase Agreement. For purposes of this Warrant, the following terms shall have the following definitions:

 

    	 	 	 

    	 

    

 

(a)
“Exercise Period Commencement Time” means 10:00 a.m. (New York City time) on the day immediately following
the Qualified Financing Closing, provided that if a Qualified Financing Closing does not occur prior to the Maturity Date of the
Holder Note, then Exercise Period Commencement Time means 10:00 a.m. (New York City time) on the day immediately following the
Maturity Date of the Holder Note.

 

(b)
“Exercise Price” means the Conversion Price set forth in the Holder Note (subject to adjustment as provided
herein), provided that if a Qualified Financing does not occur on or prior to the Maturity Date of the Holder Note, the Exercise
Price shall be equal to the price per share obtained by dividing (x) $3,000,000 by (y) the number of Fully-Diluted Shares outstanding
immediately prior to the Maturity Date.

 

(c)
“Fully-Diluted Shares” all outstanding shares of capital stock of the Company, assuming (A) the conversion
of all convertible preferred stock and the conversion or exercise of warrants, options and all other securities convertible into
or exercisable for shares of capital stock in the Company (other than the Holder Notes) regardless of whether such convertible
securities are “in the money”, and (B) the issuance of all shares of capital stock reserved for issuance under any
equity plan of the Company, including any additional stock reserved in connection with a Qualified Financing.

 

(d)
“Holder Note” means the Secured Convertible Promissory Note dated as of the date hereof, in the original principal
amount of $[_________] made by the Company and payable to the Holder.

 

(e)
“Warrant” means and includes this Warrant and any Common Stock or warrants hereafter issued as a consequence
of the exercise or transfer of this Warrant in whole or in part.

 

(f)
“Warrant Coverage Amount” means an amount equal to one hundred percent (100%) of the aggregate number of shares
of Common Stock into which the Conversion Shares issuable upon conversion of the Holder Note may be converted.

 

(g)
“Warrant Shares” means the number of shares of the Company’s Common Stock equal to the quotient obtained
by dividing the Warrant Coverage Amount by the Exercise Price.

 

(h)
“VWAP” means, for any date, the price determined by the first of the following clauses that applies: (a) if
the Common Stock is then listed or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for
such date (or the nearest preceding date) on the Trading Market on which the Common Stock is then listed or quoted as reported
by Bloomberg L.P. (based on a Trading Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB
or OTCQX is not a Trading Market, the volume weighted average price of the Common Stock for such date (or the nearest preceding
date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then listed or quoted for trading on OTCQB or OTCQX and
if prices for the Common Stock are then reported in the “Pink Sheets” published by OTC Markets Group, Inc. (or a similar
organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock
so reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser
selected in good faith by the Lead Purchaser and reasonably acceptable to the Company, the fees and expenses of which shall be
paid by the Company.

 

    	2

    	 

    

 

2.
Exercise Period. Subject to the terms and conditions set forth herein, this Warrant may be exercised at any time or from
time to time during the period commencing on Exercise Period Commencement Time and ending at the earlier to occur of (a) 5:00
p.m. (New York City time) on the tenth (10th) anniversary of the Exercise Period Commencement Date and (b) 5:00 p.m. (New York
City time) on the day immediately prior to the occurrence of a Purchaser Subscription Default with respect to the Holder (the
“Exercise Period”).

 

3.
Procedure for Exercise; Effect of Exercise.

 

(a)
Cash Exercise. This Warrant may be exercised, in whole or in part, by the Holder during normal business hours on any business
day during the Exercise Period by (i) the presentation and surrender of this Warrant to the Company at its principal office (or
such other office or agency of the Company as it may designate by notice in writing to the Holder at the address of the Holder
appearing on the books of the Company) along with a duly executed Notice of Exercise (in the form attached hereto) specifying
the number of Warrant Shares to be purchased, and (ii) delivery of payment to the Company of the Exercise Price for the number
of Warrant Shares specified in the Notice of Exercise by cash, wire transfer of immediately available funds to a bank account
specified by the Company, or by certified or bank cashier’s check.

 

(b)
Cashless Exercise. If the Warrant has been outstanding for six (6) months and there is no effective registration statement
including the Warrant Shares, this Warrant may also be exercised by the Holder through a cashless exercise, as described in this
Section 3(b). In such case, this Warrant may be exercised, in whole or in part, by the Holder during normal business hours on
any business day during the Exercise Period by the presentation and surrender of this Warrant to the Company at its principal
office (or such other office or agency of the Company as it may designate by notice in writing to the Holder at the address of
the Holder appearing on the books of the Company) along with a duly executed Notice of Exercise specifying the number of Warrant
Shares to be applied to such exercise. The number of shares of Common Stock to be issued upon exercise of this Warrant pursuant
to this Section 3(b) shall equal the value of this Warrant (or the portion thereof being canceled) computed as of the date of
delivery of this Warrant to the Company using the following formula:

 

	X
    = 	Y(A-B)

    A

Where:

 

	 	X
    = the number of shares of Common Stock to be issued to Holder under this Section 3(b);
	 	Y
    = the number of Warrant Shares identified in the Notice of Exercise as being applied to the subject exercise;
	 	A
    = the Current Market Price on such date; and
	 	B
    = the Exercise Price on such date.

 

    	3

    	 

    

 

For
purposes of this Section 3(b), Current Market Price shall have the definition provided in Section 7(g).

 

The
Company acknowledges and agrees that this Warrant was issued on the date set forth at the end of this Warrant. Consequently, the
Company acknowledges and agrees that, if the Holder conducts a cashless exercise pursuant to this Section 3(b), the period during
which the Holder held this Warrant may, for purposes of Rule 144 promulgated under the Securities Act of 1933, as amended (the
“Securities Act”), be “tacked” to the period during which the Holder holds the Warrant Shares received
upon such cashless exercise.

 

(c)
Effect of Exercise. Upon receipt by the Company of this Warrant and a Notice of Exercise, together with proper payment
of the Exercise Price, as provided in this Section 3, the Company agrees that such Warrant Shares shall be deemed to be issued
to the Holder as the record holder of such Warrant Shares as of the close of business on the date on which this Warrant has been
surrendered and payment has been made for such Warrant Shares in accordance with this Warrant and the Holder shall be deemed to
be the holder of record of the Warrant Shares, notwithstanding that the stock transfer books of the Company shall then be closed
or that certificates representing such Warrant Shares shall not then be actually delivered to the Holder. A stock certificate
or certificates for the Warrant Shares specified in the Notice of Exercise shall be delivered to the Holder as promptly as practicable,
and in any event within seven (7) business days, thereafter. The stock certificate(s) so delivered shall be in any such denominations
as may be reasonably specified by the Holder in the Notice of Exercise. If this Warrant should be exercised in part only, the
Company shall, upon surrender of this Warrant for cancellation, execute and deliver a new Warrant evidencing the right of the
Holder to purchase the balance of the Warrant Shares subject to purchase hereunder.

 

4.
Registration of Warrants; Transfer of Warrants. Any Warrants issued upon the transfer or exercise in part of this Warrant
shall be numbered and shall be registered in a Warrant Register as they are issued. The Company shall be entitled to treat the
registered holder of any Warrant on the Warrant Register as the owner in fact thereof for all purposes and shall not be bound
to recognize any equitable or other claim to or interest in such Warrant on the part of any other person, and shall not be liable
for any registration or transfer of Warrants which are registered or to be registered in the name of a fiduciary or the nominee
of a fiduciary unless made with the actual knowledge that a fiduciary or nominee is committing a breach of trust in requesting
such registration or transfer, or with the knowledge of such facts that its participation therein amounts to bad faith. This Warrant
shall be transferable only on the books of the Company upon delivery thereof duly endorsed by the Holder or by its duly authorized
attorney or representative, or accompanied by proper evidence of succession, assignment, or authority to transfer. In all cases
of transfer by an attorney, executor, administrator, guardian, or other legal representative, duly authenticated evidence of his
or its authority shall be produced. Upon any registration of transfer, the Company shall deliver a new Warrant or Warrants to
the person entitled thereto. This Warrant may be exchanged, at the option of the Holder thereof, for another Warrant, or other
Warrants of different denominations, of like tenor and representing in the aggregate the right to purchase a like number of Warrant
Shares, upon surrender to the Company or its duly authorized agent.

 

    	4

    	 

    

 

5.
Restrictions on Transfer.

 

(a)
The Holder, as of the date of issuance hereof, represents to the Company that such Holder is acquiring the Warrants for its own
account for investment purposes and not with a view to the distribution thereof or of the Warrant Shares. Notwithstanding any
provisions contained in this Warrant to the contrary, this Warrant and the related Warrant Shares shall not be transferable except
pursuant to the proviso contained in the following sentence or upon the conditions specified in this Section 4, which conditions
are intended, among other things, to insure compliance with the provisions of the Securities Act and applicable state law in respect
of the transfer of this Warrant or such Warrant Shares. The Holder by acceptance of this Warrant agrees that the Holder will not
transfer this Warrant or the related Warrant Shares prior to delivery to the Company of an opinion of the Holder’s counsel
(as such opinion and such counsel are described in Section 5(b) hereof) or until registration of such Warrant Shares under the
Securities Act has become effective or after a sale of such Warrant or Warrant Shares has been consummated pursuant to Rule 144
or Rule 144A under the Securities Act; provided, however, that the Holder may freely transfer this Warrant or such Warrant
Shares (without delivery to the Company of an opinion of counsel) (i) to one of its nominees, affiliates or a nominee thereof,
(ii) to a pension or profit-sharing fund established and maintained for its employees or for the employees of any affiliate, (iii)
from a nominee to any of the aforementioned persons as beneficial owner of this Warrant or such Warrant Shares, (iv) to a qualified
institutional buyer, so long as such transfer is effected in compliance with Rule 144A under the Securities Act, or (v) to an
accredited investor (as such term is defined in Regulation D under the Securities Act).

 

(b)
The Holder, by its acceptance hereof, agrees that prior to any transfer of this Warrant or of the related Warrant Shares (other
than as permitted by Section 5(a) hereof or pursuant to a registration under the Securities Act), the Holder will give written
notice to the Company of its intention to effect such transfer, together with an opinion of such counsel for the Holder as shall
be reasonably acceptable to the Company, to the effect that the proposed transfer of this Warrant and/or such Warrant Shares may
be effected without registration under the Securities Act. Upon delivery of such notice and opinion to the Company, the Holder
shall be entitled to transfer this Warrant and/or such Warrant Shares in accordance with the intended method of disposition specified
in the notice to the Company.

 

(c)
Each stock certificate representing Warrant Shares issued upon exercise or exchange of this Warrant and any other securities issued
in respect of the Warrant Shares upon any stock split, stock dividend, recapitalization, merger, consolidation or similar event,
shall bear the following legend (unless the opinion of counsel referred to in Section 5(b) states such legend is not required)
in addition to any other agreement to which the Holder is subject:

 

“THIS
SECURITY HAS NOT BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE
UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND,
ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT
TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN
ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT WITH
A REGISTERED BROKER-DEALER OR OTHER LOAN WITH A FINANCIAL INSTITUTION THAT IS AN “ACCREDITED INVESTOR” AS DEFINED
IN RULE 501(a) UNDER THE SECURITIES ACT OR OTHER LOAN SECURED BY SUCH SECURITIES.”

 

    	5

    	 

    

 

The
Holder understands that the Company may place, and may instruct any transfer agent or depository for the Warrant Shares to place,
a stop transfer notation in the securities records in respect of the Warrant Shares.

 

6.
Reservation of Shares. The Company shall at all times during the Exercise Period reserve and keep available out of its
authorized and unissued Common Stock, solely for the purpose of providing for the exercise of the rights to purchase all Warrant
Shares granted pursuant to the Warrants, such number of shares of Common Stock as shall, from time to time, be sufficient therefor.
The Company covenants that all shares of Common Stock issuable upon exercise of this Warrant, upon receipt by the Company of the
full Exercise Price therefor, and all shares of Common Stock issuable upon conversion of this Warrant, shall be validly issued,
fully paid, non-assessable, and free of preemptive rights, and free from all taxes, claims, liens, charges and other encumbrances.

 

7.
Certain Adjustments.

 

(a)
The Exercise Price shall be subject to adjustment from time to time as follows:

 

(i)
In the event that the Company shall (A) pay a dividend or make a distribution to all its stockholders, in shares of Common Stock,
on any class of capital stock of the Company or any subsidiary which is not directly or indirectly wholly owned by the Company,
(B) split or subdivide its outstanding Common Stock into a greater number of shares, or (C) combine its outstanding Common Stock
into a smaller number of shares, then in each such case the Exercise Price in effect immediately prior thereto shall be adjusted
so that the Holder of a Warrant thereafter surrendered for Exercise shall be entitled to receive the number of shares of Common
Stock that such Holder would have owned or have been entitled to receive after the occurrence of any of the events described above
had such Warrant been exercised immediately prior to the occurrence of such event. An adjustment made pursuant to this Section
7(a)(i) shall become effective immediately after the close of business on the record date in the case of a dividend or distribution
(except as provided in Section 7(e) below) and shall become effective immediately after the close of business on the effective
date in the case of such subdivision, split or combination, as the case may be. Any shares of Common Stock issuable in payment
of a dividend shall be deemed to have been issued immediately prior to the close of business on the record date for such dividend
for purposes of calculating the number of outstanding shares of Common Stock under clauses (c) and (d) below.

 

(ii)
No adjustment in the Exercise Price shall be required unless the adjustment would require an increase or decrease of at least
1% in the Exercise Price then in effect; provided, however, that any adjustments that by reason of this Section 7(a) are
not required to be made shall be carried forward and taken into account in any subsequent adjustment. All calculations under this
Section 7(a) shall be made to the nearest cent or nearest 1/100th of a share.

 

    	6

    	 

    

 

(iii)
The Company from time to time may reduce the Exercise Price by any amount for any period of time in the discretion of the Board
of Directors. A voluntary reduction of the Exercise Price does not change or adjust the Exercise Price otherwise in effect for
purposes of this Section 7(a).

 

(iv)
In the event that, at any time as a result of an adjustment made pursuant to Section 7(a)(i) or 7(a)(ii) above, the Holder of
any Warrant thereafter surrendered for exercise shall become entitled to receive any shares of the Company other than shares of
the Common Stock, thereafter the number of such other shares so receivable upon exercise of any such Warrant shall be subject
to adjustment from time to time in a manner and on terms as nearly equivalent as practicable to the provisions with respect to
the Common Stock contained in Section 7(a)(i) or 7(a)(ii) above, and the other provisions of this Section 7(a) with respect to
the Common Stock shall apply on like terms to any such other shares.

 

(b)
In case of any reclassification of the Common Stock (other than in a transaction to which Section 7(a)(i) applies), any consolidation
of the Company with, or merger of the Company into, any other entity, any merger of another entity into the Company (other than
a merger that does not result in any reclassification, conversion, exchange or cancellation of outstanding shares of Common Stock
of the Company), any sale or transfer of all or substantially all of the assets of the Company or any compulsory share exchange,
pursuant to which share exchange the Common Stock is converted into other securities, cash or other property, then lawful provision
shall be made as part of the terms of such transaction whereby the Holder of a Warrant then outstanding shall have the right thereafter,
during the period such Warrant shall be exercisable, to exercise such Warrant only for the kind and amount of securities, cash
and other property receivable upon the reclassification, consolidation, merger, sale, transfer or share exchange by a holder of
the number of shares of Common Stock of the Company into which a Warrant might have been able to exercise for immediately prior
to the reclassification, consolidation, merger, sale, transfer or share exchange assuming that such holder of Common Stock failed
to exercise rights of election, if any, as to the kind or amount of securities, cash or other property receivable upon consummation
of such transaction subject to adjustment as provided in Section 7(a) above following the date of consummation of such transaction.
The provisions of this Section 7(b) shall similarly apply to successive reclassifications, consolidations, mergers, sales, transfers
or share exchanges.

 

    	7

    	 

    

 

(c)
If (i) the Company shall take any action which would require an adjustment in the Exercise Price pursuant to Section 7(a); (ii)
the Company shall authorize the granting to the holders of its Common Stock generally of rights, warrants or options to subscribe
for or purchase any shares of any class or any other rights, warrants or options; (iii) there shall be any reclassification or
change of the Common Stock (other than a subdivision or combination of its outstanding Common Stock or a change in par value)
or any consolidation, merger or statutory share exchange to which the Company is a party and for which approval of any stockholders
of the Company is required, or the sale or transfer of all or substantially all of the assets of the Company; or (iv) there shall
be a voluntary or involuntary dissolution, liquidation or winding up of the Company; then, in each such case, the Company shall
cause to be filed with the transfer agent for the Warrants and shall cause to be mailed to each Holder at such Holder’s
address as shown on the books of the transfer agent for the Warrants, as promptly as possible, but at least 30 days prior to the
applicable date hereinafter specified, a notice stating (A) the date on which a record is to be taken for the purpose of such
dividend, distribution or granting of rights, warrants or options, or, if a record is not to be taken, the date as of which the
holders of Common Stock of record to be entitled to such dividend, distribution or rights, warrants or options are to be determined,
or (B) the date on which such reclassification, change, consolidation, merger, statutory share exchange, sale, transfer, dissolution,
liquidation or winding-up is expected to become effective or occur, and the date as of which it is expected that holders of Common
Stock of record shall be entitled to exchange their shares of Common Stock for securities or other property deliverable upon such
reclassification, change, consolidation, merger, statutory share exchange, sale, transfer, dissolution, liquidation or winding
up. Failure to give such notice or any defect therein shall not affect the legality or validity of the proceedings described in
this Section 7(c).

 

(d)
Whenever the Exercise Price is adjusted as herein provided, the Company shall promptly file with the transfer agent for the Warrants
a certificate of an officer of the Company setting forth the Exercise Price after the adjustment and setting forth a brief statement
of the facts requiring such adjustment and a computation thereof. The Company shall promptly cause a notice of the adjusted Exercise
Price to be mailed to each Holder.

 

(e)
In any case in which Section 7(a) provides that an adjustment shall become effective immediately after a record date for an event
and the date fixed for such adjustment pursuant to Section 7(a) occurs after such record date but before the occurrence of such
event, the Company may defer until the actual occurrence of such event (i) issuing to the Holder of any Warrants exercised after
such record date and before the occurrence of such event the additional shares of Common Stock issuable upon such conversion by
reason of the adjustment required by such event over and above the Common Stock issuable upon such exercise before giving effect
to such adjustment, and (ii) paying to such holder any amount in cash in lieu of any fraction pursuant to Section 7(h).

 

(f)
In case the Company shall take any action affecting the Common Stock, other than actions described in this Section 7, which in
the opinion of the Board of Directors would materially adversely affect the exercise right of the Holders, the Exercise Price
may be adjusted, to the extent permitted by law, in such manner, if any, and at such time, as the Board of Directors may determine
to be equitable in the circumstances; provided, however, that in no event shall the Board of Directors be required to take
any such action.

 

(g)
For the purpose of any computation under Section 3(b) or this Section 7, the “Current Market Price” per share
of Common Stock shall mean the VWAP of the Common Stock on the day in question.

 

(h)
The Company shall not be required to issue fractions of shares of Common Stock or other capital stock of the Company upon the
exercise of this Warrant. If any fraction of a share would be issuable on the exercise of this Warrant (or specified portions
thereof), the Company shall purchase such fraction for an amount in cash equal to the same fraction of the Current Market Price
of such share of Common Stock on the date of exercise of this Warrant.

 

    	8

    	 

    

 

8.
Transfer Taxes. The issuance of any shares or other securities upon the exercise of this Warrant, and the delivery of certificates
or other instruments representing such shares or other securities, shall be made without charge to the Holder for any tax or other
charge in respect of such issuance. The Company shall not, however, be required to pay any tax which may be payable in respect
of any transfer involved in the issue and delivery of any certificate in a name other than that of the Holder and the Company
shall not be required to issue or deliver any such certificate unless and until the person or persons requesting the issue thereof
shall have paid to the Company the amount of such tax or shall have established to the satisfaction of the Company that such tax
has been paid.

 

9.
Loss or Mutilation of Warrant. Upon receipt of evidence reasonably satisfactory to the Company of the loss, theft, destruction,
or mutilation of any Warrant (and upon surrender of any Warrant if mutilated), and upon reimbursement of the Company’s reasonable
incidental expenses, the Company shall execute and deliver to the Holder thereof a new Warrant of like date, tenor, and denomination
in lieu of the lost, stolen, destroyed or mutilated Warrant or stock certificate provided, however, that, if the Company’s
stock is publicly traded, the Company may require the posting of a bond in an amount and nature as is customary and reasonable
given the circumstances.

 

10.
No Rights as a Stockholder. The Holder of any Warrant shall not have, solely on account of such status, any rights of a
stockholder of the Company, either at law or in equity, or to any notice of meetings of stockholders or of any other proceedings
of the Company, except as provided in this Warrant.

 

11.
Stockholder Agreements. This Warrant and the Warrant Shares exercisable hereunder are subject to the terms of each of those
certain Investors’ Rights Agreement, Right of First Refusal Agreement and Voting Agreement, as each may be amended or restated
from time to time, each dated November 15, 2019 (collectively, and as the same may hereafter be amended, the “Stockholder
Agreements”). In the event that Holder is not already a party to each of the Stockholder Agreements, as a condition precedent
to the Company’s issuance of any of the Warrant Shares exercisable hereunder, Holder shall execute an adoption agreement
in a form acceptable to the Company providing that Holder become a party as an “Investor” to each of the Stockholder
Agreements.

 

12.
Governing Law. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall
be governed by and construed and enforced in accordance with the internal laws of the State of Nevada, without regard to the principles
of conflicts of law thereof.

 

13.
Notices. All notices and other communications hereunder shall be in writing and shall be deemed given if delivered personally,
by commercial delivery service, mailed by registered or certified mail (return receipt requested), sent via facsimile (with confirmation
of receipt) or electronic mail to the parties at the address for each party, as set forth in the introductory paragraph with respect
to the Holder and in the case of the Company, at 201 E. Kennedy Blvd, Suite 700, Tampa, Florida 33602.

 

14.
Purchaser Subscription Default. For the avoidance of doubt, this Warrant shall terminate immediately upon the occurrence
of a Purchaser Subscription Default with respect to the Holder and any Warrants Shares issued by the Company on, prior to or following
the occurrence of such a Purchaser Subscription Default with respect to the Holder shall be null and void, ab initio, without
further action or notice.

 

15.
Acceptance of Warrant. By acceptance of this Warrant, the Holder accepts and agrees to be bound by all of the terms and
provisions set forth herein.

 

*
* *

 

    	9

    	 

    

 

Issuance
date: ________________, 2020

 

	 	H-CYTE,
    INC.
	 	 	 
	 	By:
    	 
	 	Name:	William
    E. Horne
	 	Title:	Chief
    Executive Officer

 

Signature
Page to Warrant Issued to [PURCHASER]

 

    	 	 	 

    	 

    

 

FORM
OF ASSIGNMENT

 

(To
be executed by the registered holder if such holder desires to transfer the attached Warrant.)

 

FOR
VALUE RECEIVED, ___________________ hereby sells, assigns, and transfers unto __________________ a Warrant to purchase the Warrant
Shares, together with all right, title, and interest therein, and does hereby irrevocably constitute and appoint _________________
attorney to transfer such Warrant on the books of the Company, with full power of substitution.

 

	 	Dated:	 
	 	 	 
	 	By:
    	 
	 	 	Print
    Name
	 	 	 
	 	 	 
	 	 	Signature

 

The
signature on the foregoing Assignment must correspond to the name as written upon the face of this Warrant in every particular,
without alteration or enlargement or any change whatsoever.

 

    	 	 	 

    	 

    

 

	To:	H-Cyte,
    Inc.	 
	 	201
    E. Kennedy Blvd, Suite 700	 
	 	Tampa,
    FL 33602	 
	 	Attention:
    Chief Executive Officer	 

 

NOTICE
OF EXERCISE

 

The
undersigned hereby exercises his or its rights to purchase _______ Warrant Shares covered by the within Warrant and tenders payment
herewith in the amount of $_________ by [tendering cash or delivering a certified check or bank cashier’s check, payable
to the order of the Company] [surrendering ______ shares of Common Stock received upon exercise of the attached Warrant, which
shares have a Current Market Price equal to such payment] in accordance with the terms thereof, and requests that certificates
for such securities be issued in the name of, and delivered to:

 

_______________________________________

 

_______________________________________

 

_______________________________________

 

(Print
Name, Address and Social Security

or
Tax Identification Number)

 

and,
if such number of Warrant Shares shall not be all the Warrant Shares covered by the within Warrant, that a new Warrant for the
balance of the Warrant Shares covered by the within Warrant be registered in the name of, and delivered to, the undersigned at
the address stated below.

 

	 	Dated:	 
	 	 	 
	 	By:
    	 
	 	 	Print
    Name
	 	 	 
	 	 	 
	 	 	Signature
	 	 	 

Address:

 

___________________________________________

___________________________________________

___________________________________________

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00307-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00307-of-00352.parquet"}]]